Source: |
Type: |
PDK1 (3-phosphoinositide-dependent protein kinase-1) (PDPK1) is a serine/threonine kinase that plays a crucial role in various cellular processes, including cell growth, survival, and metabolism. It is a key component of the PI3K/Akt signaling pathway, which is often dysregulated in cancer. Overexpression or hyperactivation of PDK1 can lead to increased cell proliferation, survival, and resistance to apoptosis, contributing to tumorigenesis. Inhibitors of PDK1 are being explored in preclinical and clinical studies as a means to disrupt cancer cell growth and survival. |
267- | ALA, | α-Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells |
- | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | PC9 |
999- | Ba, | Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer |
- | in-vitro, | Lung, | H460 |
2620- | Ba, | Natural compounds targeting glycolysis as promising therapeutics for gastric cancer: A review |
- | Review, | GC, | NA |
2617- | Ba, | Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review |
- | Review, | Var, | NA |
2616- | Ba, | The Role of HK2 in Tumorigenesis and Development: Potential for Targeted Therapy with Natural Products |
- | Review, | Var, | NA |
2295- | Ba, | 5-FU, | Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway |
- | in-vitro, | GC, | AGS |
2298- | Ba, | Flavonoids Targeting HIF-1: Implications on Cancer Metabolism |
- | Review, | Var, | NA |
2473- | BA, | Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | BEAS-2B | - | in-vitro, | Lung, | H460 |
2702- | BBR, | The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1 |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1975 |
2710- | BBR, | Berberine inhibits the Warburg effect through TET3/miR-145/HK2 pathways in ovarian cancer cells |
- | in-vitro, | Ovarian, | SKOV3 |
943- | BetA, | Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-κB/c-Myc pathway |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
2716- | BetA, | Cellular and molecular mechanisms underlying the potential of betulinic acid in cancer prevention and treatment |
- | Review, | Var, | NA |
2738- | BetA, | Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 | - | in-vivo, | NA, | NA |
1259- | CAP, | Capsaicin inhibits HIF-1α accumulation through suppression of mitochondrial respiration in lung cancer cells |
- | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H23 | - | in-vitro, | Lung, | H2009 |
2398- | CGA, | Polyphenol-rich diet mediates interplay between macrophage-neutrophil and gut microbiota to alleviate intestinal inflammation |
- | in-vivo, | Col, | NA |
1145- | CHr, | Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways |
- | in-vitro, | Cerv, | HeLa |
2781- | CHr, | PBG, | Chrysin a promising anticancer agent: recent perspectives |
- | Review, | Var, | NA |
2785- | CHr, | Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin |
- | Review, | Var, | NA |
1591- | Citrate, | The biological significance of cancer: mitochondria as a cause of cancer and the inhibition of glycolysis with citrate as a cancer treatment |
- | Analysis, | NA, | NA |
133- | CUR, | Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis |
- | in-vitro, | Pca, | NA |
463- | CUR, | Curcumin induces autophagic cell death in human thyroid cancer cells |
- | in-vitro, | Thyroid, | K1 | - | in-vitro, | Thyroid, | FTC-133 | - | in-vitro, | Thyroid, | BCPAP | - | in-vitro, | Thyroid, | 8505C |
1871- | DAP, | Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth |
- | in-vitro, | AML, | U937 | - | in-vivo, | AML, | NA |
1864- | DCA, | MET, | Dichloroacetate Enhances Apoptotic Cell Death via Oxidative Damage and Attenuates Lactate Production in Metformin-Treated Breast Cancer Cells |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | T47D | - | in-vitro, | Nor, | MCF10 |
1608- | EA, | Ellagic Acid from Hull Blackberries: Extraction, Purification, and Potential Anticancer Activity |
- | in-vitro, | Cerv, | HeLa | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HUVECs |
960- | HNK, | Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth |
- | vitro+vivo, | BC, | MCF-7 | - | vitro+vivo, | BC, | MDA-MB-231 |
2044- | PB, | DCA, | Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate |
- | in-vivo, | NA, | NA |
998- | PB, | Phenyl butyrate inhibits pyruvate dehydrogenase kinase 1 and contributes to its anti-cancer effect |
- | in-vivo, | NA, | NA |
2380- | PBG, | Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy |
- | Review, | Var, | NA |
2471- | RES, | Resveratrol Regulates Glucose and Lipid Metabolism in Diabetic Rats by Inhibition of PDK1/AKT Phosphorylation and HIF-1α Expression |
- | in-vivo, | Diabetic, | NA |
2472- | RES, | Resveratrol Restores Sirtuin 1 (SIRT1) Activity and Pyruvate Dehydrogenase Kinase 1 (PDK1) Expression after Hemorrhagic Injury in a Rat Model |
- | in-vivo, | Nor, | NA |
- | vitro+vivo, | Lung, | NA |
2470- | SK, | PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism |
- | in-vitro, | Lung, | H1299 |
2469- | SK, | Shikonin induces the apoptosis and pyroptosis of EGFR-T790M-mutant drug-resistant non-small cell lung cancer cells via the degradation of cyclooxygenase-2 |
- | in-vitro, | Lung, | H1975 |
2125- | TQ, | Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis |
- | in-vitro, | RCC, | RCC4 | - | in-vitro, | RCC, | Caki-1 |
3140- | VitC, | Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest |
- | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | Nor, | HEK293 |
3142- | VitC, | Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF12A |
1067- | VitC, | Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer |
- | in-vivo, | CRC, | NA |
2301- | Wog, | Flavonoids Targeting HIF-1: Implications on Cancer Metabolism |
- | Review, | Var, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:246 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid